Trial intelligence / Profile preview

Platelet-rich plasma infiltration for trochanteric hip bursitis

RBR-82gqqkPhase 2Completed

Sponsor
Faculty of Medical Sciences of Santa Casa de São Paulo
Start
Jul 2011
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, single-blind trial of platelet-rich plasma and triamcinolone hexacetonide in trochanteric bursitis (2 arms), sponsored by Faculty of Medical Sciences of Santa Casa de São Paulo. Started Jul 2011; status: completed.

02

Drugs

platelet-rich plasmatriamcinolone hexacetonide
03

Conditions

trochanteric bursitis

Beyond the preview

Go deeper on RBR-82gqqk.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-82gqqk.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call